Merck & Co Inc

NYSE:MRK   3:59:59 PM EDT
-0.69 (-0.90%)
4:00:00 PM EDT: $76.18 0.00 (0.00%)
Products, Regulatory

MSD Announces Supply Agreement With U.S. Government For Molnupiravir, An Investigational Oral Antiviral Candidate For Treatment Of Mild To Moderate Covid-19

Published: 06/17/2021 14:52 GMT
Merck & Co Inc (MRK) - Msd Announces Supply Agreement With U.S. Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate Covid-19.
Merck & Co Inc - Plans to Submit Applications for Emergency Use Or Approval to Regulatory Bodies Outside of U.S.merck & Co Inc - is Currently in Discussions With Other Countries Interested in Advance Purchase Agreements for Molnupiravir.
Merck & Co Inc - Expects to Have More Than 10 Million Courses of Therapy Available by End of 2021.